Access to pharmaceutical innovation for patients is not solely a healthcare issue; it is a strategic indicator of resilience, social cohesion and economic dynamism, reflecting the extent to which a…
Transition to a Value-Based Healthcare system can put Greece back on the innovation map – Η ΝΑΥΤΕΜΠΟΡΙΚΗ